Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 3.44 -0.1 (2.82%)
Previous Close $3.54    52 Week High
Open $3.36    52 Week Low
Day High $3.54    P/E N/A 
Day Low $3.26    EPS
Volume 17,442